Cefprozil and Emesis - a phase IV clinical study of FDA data

Summary:

Emesis is reported as a side effect among people who take Cefprozil (cefprozil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Symbicort, and have Asthma.

The phase IV clinical study analyzes which people have Emesis when taking Cefprozil. It is created by eHealthMe based on reports of 1,051 people who have side effects when taking Cefprozil from the FDA, and is updated regularly.

What is Cefprozil?

Cefprozil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,103 Cefprozil users. Check the latest studies of Cefprozil.

What is Emesis?

Emesis (process of vomiting) is found to be associated with 4,451 drugs and 5,759 conditions by eHealthMe. Check the latest studies of Emesis.

On Apr, 27, 2026

1,051 people reported to have side effects when taking Cefprozil.
Among them, 76 people (7.23%) have Emesis.

Among these 76 people:

How long have people been on Cefprozil when they have Emesis? *

What is the gender of people who have Emesis when taking Cefprozil? *

female: 89.55 %
male: 10.45 %

What is the age of people who have Emesis when taking Cefprozil? *

What are other drugs people take besides Cefprozil? *

What are other side effects people have besides Emesis? *

Diarrhea: 36 people, 47.37%
Nausea (feeling of having an urge to vomit): 31 people, 40.79%
Pneumonia: 28 people, 36.84%
Productive Cough: 21 people, 27.63%
Sputum Discolored: 21 people, 27.63%
Dyspnea Exertional: 21 people, 27.63%
Cough: 20 people, 26.32%
Wheezing (a high-pitched whistling sound made while you breath): 18 people, 23.68%
Fever: 18 people, 23.68%
Weakness: 17 people, 22.37%

What are the existing conditions these people have? *

Asthma: 30 people, 39.47%
Osteoporosis (bones weak and more likely to break): 19 people, 25.00%
Muscle Spasms (muscle contraction): 13 people, 17.11%
Pain: 11 people, 14.47%
Joint Pain: 10 people, 13.16%
Hypersensitivity: 10 people, 13.16%
High Blood Pressure: 10 people, 13.16%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 10 people, 13.16%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 13.16%
Stress And Anxiety: 10 people, 13.16%

* Approximation only. Some reports may have incomplete information.

Do you take Cefprozil and have Emesis?

- Check whether Emesis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefprozil:

Cefprozil (1,103 reports)

Emesis treatments and more:

Emesis (529,395 reports)

Browse all side effects of Cefprozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Emesis:

Emesis (4,451 drugs)

Browse all the conditions that are associated with Emesis:

Emesis (5,759 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefprozil (the active ingredients of Cefprozil) and Cefprozil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.